CAMBRIDGE, Mass., Aug. 25, 2022 -- Aktis Oncology, a biotechnology company discovering and developing novel classes of targeted alpha radiopharmaceuticals to treat a broad range of solid tumors, today announced...
Eric Linsley will lead a discussion on "Partnering and Licensing in Neurotech" at the 2012 Neurotech Investing & Partnering Conference on May 21-22 in Boston.
News | 02. 21. 2012
Eric Linsley will lead a discussion on "Partnering and Licensing in Neurotech" at the 2012 Neurotech Investing & Partnering Conference on May 21-22 in Boston.
